Home Institution

University of South Carolina

Publication Date

Fall 2017

Program Name

Kenya: Urbanization, Health, and Human Rights


Human Immunodeficiency Virus (HIV) suppresses the immune system by attacking T cells, leading to the development of acquired immunodeficiency syndrome (AIDS). HIV affects over 30 million people around the world and 1.6 million people in Kenya. On August 18, 1987, the FDA sanctioned the first human testing of a candidate vaccine for HIV. Currently, multiple HIV vaccines—projected to be on the market in five to ten years—are being tested for efficacy and safety. The goal of this study was to explore opinions related to the HIV vaccine so that there is a guide for future policy development in Western Kenya. This study included a survey and focus groups taken from a convenience sample at various locations within Kisumu in Kisumu County and Sidindi in Siaya County. The study found that most participants would get vaccinated if the HIV vaccine became available (87.7%), and the majority of participants support a compulsory vaccination campaign for children (81.18%).


African Languages and Societies | African Studies | Community Health and Preventive Medicine | Health Communication | Health Policy | Immunology and Infectious Disease | Infectious Disease | Medicine and Health Sciences | Preventive Medicine


Article Location